Home Florida Cities with Medical Doctor Providers Bonita Springs

Medical Doctor REBECCA KOSLOFF

REBECCA KOSLOFF is a Florida Medical Doctor with their office listed as being located at: 9776 BONITA BEACH ROAD SE in BONITA SPRINGS, Florida 34135 Any education information we have on file, publications, awards, certifications, hospital priviliges, directions can be found below. Thanks and we hope you find what you are looking for.

Get mobile directions from current location:

---

FL License Details
Full Name: REBECCA KOSLOFF
License: ME95691
Profession Name: Medical Doctor
License Created on: 04/21/2006
City: BONITA SPRINGS
Prescribing Indicator: Y

---

---

Listed Education

---

Bachelor's Information:
Degree Earned: MD
Education Major: Medicine

---

Internships, Residency Programs, Fellowships etc
Program Location:Beth Israel Medical Center
Program:IM - INTERNAL MEDICINE
Program Type:INTERNSHIP
Began:a
Program Location:Beth Israel Medical Center
Program:IM - INTERNAL MEDICINE
Program Type:RESIDENCY
Began:a
Program Location:New York University Medical Center
Program:IM - HEMATOLOGY AND ONCOLOGY
Program Type:FELLOWSHIP
Began:a

---

Certifications

IM - ONCOLOGY from AMERICAN BOARD OF INTERNAL MEDICINE

---

Hospital Privileges

Hospital and state it is in: NAPLES COMMUNITY HOSPITAL in FL
Hospital and state it is in: NORTH COLLIER HOSPITAL in FL
Hospital and state it is in: PHYSICIANS REGIONAL HOSPITAL in FL
Hospital and state it is in: PHYSICIANS REGIONAL HOSPITAL in FL

---

Article Publications

Article title, publication, and date: FLUOXETINE ALLEVIATES BEHAVIORAL DEPRESSION at NEUROPSYCHOPHARMACOLOGY on 04/27/2011
Article title, publication, and date: PHASE I STUDY OF THE COMBINATION OF BKM120 AND BEVACIZUMAB I at JOURNAL OF CLINICAL ONCOLOGY on 01/01/2013
Article title, publication, and date: SORAFENIB AND CONTINUED ERLOTINIB OR SORAFENIB ALONE IN PATI at JOURNAL OF CLINICAL ONCOLOGY on 01/01/2012
Article title, publication, and date: Exceptional Response to Pembrolizumab in a Patient with Cast at Journal of Oncology on 04/09/2019
Article title, publication, and date: Sorafenib and continued erlotinib or sorafenib alone in pati at Lung Cancer 2017 on 09/18/2017